In this podcast episode, CANCER BUZZ speaks with Nicole Dreibelbis, certified registered nurse practitioner specializing in women’s health at UPMC Magee Cancer Center in central Pennsylvania.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
Female sexual dysfunction is a well-studied adverse effect of cancer treatment. Despite its prevalence, however, it remains vastly underdiagnosed and undertreated in oncology patients, with providers inadequately addressing sexual function before, during, and after treatment. Although most patients prefer that their providers initiate conversations regarding sexual health, providers may be reticent to screen for such problems due to insufficient knowledge and expertise in the diagnosis and management of female sexual dysfunction. In this podcast episode, CANCER BUZZ speaks with Nicole Dreibelbis, certified registered nurse practitioner specializing in women’s health at UPMC Magee Cancer Center in central Pennsylvania.
“Sexual health is a part of everyone’s well-being [and] is important. I think we need to start addressing that, in survivorship and even prior, for patients to be able to get the most out of their lives. Because that’s the whole point of our treatments—to make sure that we’re giving them more life. We want that life to be as good as possible.”—Nicole Dreibelbis, CRNP, WHNP-BC
Guest:
Nicole Dreibelbis, CRNP, WHNP-BC
Gynecologic Oncology Nurse Practitioner
UPMC Magee Cancer Center
Mechanicsburg, PA
Resources
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
